Companies › QTRX
QUANTERIX CORP (QTRX)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001503274 · EDGAR filings · Updated 2026-07-16
QUANTERIX CORP (QTRX) has reported institutional ownership of 77.4%, with 127 institutional managers holding positions valued at $128.4M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).
Latest updates
- 2026-07-16 — Insider transaction reported (Form 4)
- 2026-07-16 — Insider transaction reported (Form 4)
- 2026-07-09 — Insider transaction reported (Form 4)
- 2026-07-09 — Insider transaction reported (Form 4)
- 2026-07-02 — Insider transaction reported (Form 4)
- 2026-07-02 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, QUANTERIX CORP has 127 institutional holders and institutional ownership of 77.4%.
Insider activity
Insiders reported 88 transactions (7 buys, 0 sells) across 14 reporting insiders, with a net reported value of $2.89M.
Data flags from SEC filings
Related companies
ELEDON PHARMACEUTICALS INC (ELDN) · INFUSYSTEM HLDGS INC (INFU) · VOYAGER THERAPEUTICS INC (VYGR) · INNOVAGE HLDG CORP (INNV) · EDITAS MEDICINE INC (EDIT) · HERON THERAPEUTICS INC (HRTX)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-16.